XML 77 R67.htm IDEA: XBRL DOCUMENT
v3.25.3

Expenses - Summary of expenses (Detail) - AUD ($) $ in Thousands | 12 Months Ended
--- | ---
Jun. 30, 2025 | Jun. 30, 2024 | Jun. 30, 2023
Loss before income tax includes the following specific |  |  |
Scientific Advisory Board costs | $ 0 | $ 0 | $ 31
Employee benefits expense- salaries & wages and staff benefits | 1,761 | 2,161 | 2,250
Employee benefits expense- superannuation | 34 | 36 | 29
Employee benefits expense- share based payments | 172 | 485 | 702
Total research & development expense (excluding amortisation) | 6,391 | 15,511 | 13,695
Amortisation | 934 | 1,869 | 1,869
Total research & development expense | 7,325 | 17,380 | 15,564
Net foreign exchange loss/(gain) | 310 | (20) | 46
Expense relating to short term lease | 59 | 124 | 152
Defined contribution superannuation expense | 54 | 88 | 131
Employee benefits expense G&A |  |  |
- salaries & wages and staff benefits | 1,062 | 486 | 1,467
- superannuation | 20 | 52 | 102
- share based payments | 481 | 48 | 457
Total employee benefits expense G&A | 1,563 | 586 | 2,026
EVT-801 program costs [member] |  |  |
Loss before income tax includes the following specific |  |  |
Research and development expense | 1,391 | 5,277 | 5,060
Cantrixil program costs [member] |  |  |
Loss before income tax includes the following specific |  |  |
Research and development expense | 2 | 1 | 5
Paxalisib program costs [member] |  |  |
Loss before income tax includes the following specific |  |  |
Research and development expense | 3,031 | 7,551 | 5,618
Paxalisib licensing agreement [member] |  |  |
Loss before income tax includes the following specific |  |  |
Amortisation | 542 | 1,084 | 1,084
Evotec Licensing Agreement [member] |  |  |
Loss before income tax includes the following specific |  |  |
Amortisation | $ 392 | $ 785 | $ 785

X
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 38 -IssueDate 2025-01-01 -Paragraph 118 -Subparagraph e -Clause vi -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_vi&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 263 -Subparagraph e -Clause vi -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e_vi&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 263 -Subparagraph e -Clause vi -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e_vi&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 19 -IssueDate 2025-01-01 -Paragraph 5 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_5&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 19 -IssueDate 2025-01-01 -Paragraph 135 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_135_b&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 19 -IssueDate 2025-01-01 -Paragraph 53 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_53&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 203 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_203&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 203 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_203&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_ProfitLossAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Expense related to short term leases. + References No definition available. + Details
Name: | kzia_ExpenseRelatedToShortTermLeases
Namespace Prefix: | kzia_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition General and administration expenses employee benfits [Abstract]. + References No definition available. + Details
Name: | kzia_GeneralAndAdministrationExpensesEmployeeBenfitsAbstract
Namespace Prefix: | kzia_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition General and administration expenses salaries wages and staff benefits. + References No definition available. + Details
Name: | kzia_GeneralAndAdministrationExpensesSalariesWagesAndStaffBenefits
Namespace Prefix: | kzia_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition General and administration expenses share based payment expenses employees. + References No definition available. + Details
Name: | kzia_GeneralAndAdministrationExpensesShareBasedPaymentExpensesEmployees
Namespace Prefix: | kzia_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition General and administration expenses superannuation expenses. + References No definition available. + Details
Name: | kzia_GeneralAndAdministrationExpensesSuperannuationExpenses
Namespace Prefix: | kzia_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition General and administration expenses total employee benefits. + References No definition available. + Details
Name: | kzia_GeneralAndAdministrationExpensesTotalEmployeeBenefits
Namespace Prefix: | kzia_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Net foreign exchange gain loss. + References No definition available. + Details
Name: | kzia_NetForeignExchangeGainLoss
Namespace Prefix: | kzia_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Research and development employee benefits expense share based payments + References No definition available. + Details
Name: | kzia_ResearchAndDevelopmentEmployeeBenefitsExpenseShareBasedPayments
Namespace Prefix: | kzia_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Research and development employee benefits expense superannuation + References No definition available. + Details
Name: | kzia_ResearchAndDevelopmentEmployeeBenefitsExpenseSuperannuation
Namespace Prefix: | kzia_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Research and development expense excluding employee benefits expense + References No definition available. + Details
Name: | kzia_ResearchAndDevelopmentExpenseExcludingEmployeeBenefitsExpense
Namespace Prefix: | kzia_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Research and development expenses excluding amortization. + References No definition available. + Details
Name: | kzia_ResearchAndDevelopmentExpensesExcludingAmortization
Namespace Prefix: | kzia_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Scientific advisory board costs. + References No definition available. + Details
Name: | kzia_ScientificAdvisoryBoardCosts
Namespace Prefix: | kzia_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Total research and development expenses. + References No definition available. + Details
Name: | kzia_TotalResearchAndDevelopmentExpenses
Namespace Prefix: | kzia_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | kzia_ProgramAxis=kzia_Evt801programCostsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | kzia_ProgramAxis=kzia_CantrixilprogramCostsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | kzia_ProgramAxis=kzia_PaxalisibprogramCostsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=kzia_PaxalisibLicensingAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=kzia_EvotecLicensingAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |